PSTV (Plus Therapeutics) Buyback Yield %: -129.44 (As of Jul. 01, 2026)


PSTV Plus Therapeutics Inc PSTV
26 GF Score
Price $4.35
! 2 Warning Signs
View Full Analysis

What is Plus Therapeutics Buyback Yield %?

Plus Therapeutics PSTV +1.63% 26 Buyback Yield % is -129.44 as of Jul. 01, 2026. GuruFocus rates PSTV with a GF Score™ of 26/100. The stock has 2 warning signs investors should review. Among 742 Biotechnology companies, Plus Therapeutics ranks worse than 92.32% on this metric.

Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.

Plus Therapeutics's current buyback yield was -129.44%.

Plus Therapeutics Buyback Yield % Historical Data

* Premium members only.

The historical data trend for Plus Therapeutics's Buyback Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Plus Therapeutics Buyback Yield % Chart

Plus Therapeutics Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Buyback Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -115.68 -147.98 -69.35 -101.56 -54.25

Plus Therapeutics Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Buyback Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -136.77 -55.51 -39.50 -54.25 -138.96

PSTV vs KYNB, VTGN, TVGN: Buyback Yield % Comparison

For the Biotechnology subindustry, Plus Therapeutics's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Plus Therapeutics Buyback Yield % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Plus Therapeutics's Buyback Yield % distribution charts can be found below:

* The bar in red indicates where Plus Therapeutics's Buyback Yield % falls into.


PSTV
26GF Score
Plus Therapeutics Inc PSTV
Buyback Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Plus Therapeutics Buyback Yield % Calculation

Buyback yield is a measure of shareholder return.

Plus Therapeutics's Buyback Yield for the fiscal year that ended in Dec. 2025 is calculated as

Buyback Yield=Net Issuance of Stock / Market Cap
=- (Repurchase of Stock + Issuance of Stock) / Market Cap
=- (0 + 38.541) / 71.0432025
=-54.25%

Plus Therapeutics's annualized Buyback Yield for the quarter that ended in Mar. 2026 is calculated as

Buyback Yield=Net Issuance of Stock(TTM) / Market Cap
=- (Repurchase of Stock + Issuance of Stock) (TTM)** / Market Cap
=- (0 + 38.761) / 27.89403
=-138.96%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** If the quarter corresponds to the year-end period, we will use the annual Repurchase of Stock and Issuance of Stock data .

Frequently Asked Questions Learn more about Buyback Yield % →
What does a Buyback Yield % of -129.44 mean?
Plus Therapeutics (PSTV) has a Buyback Yield % of -129.44 as of Jul. 01, 2026. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Plus Therapeutics and its competitors. According to the industry distribution chart, Plus Therapeutics ranks #685 out of 742 companies in the Biotechnology industry, placing it in the top 92.3%.
Is Plus Therapeutics' Buyback Yield % too high?
Plus Therapeutics' current Buyback Yield % is -129.44. Based on the distribution chart, Plus Therapeutics ranks #685 out of 742 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Plus Therapeutics has a GF Score™ of 26/100, reflecting its overall financial health beyond just this single metric.
How does Plus Therapeutics' Buyback Yield % compare to KYNB and VTGN?
According to the Biotechnology industry distribution chart, Plus Therapeutics ranks #685 out of 742 companies for Buyback Yield %. This places Plus Therapeutics in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Buyback Yield % for a Biotechnology company?
A good Buyback Yield % depends on the Biotechnology industry context. However, Buyback Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Buyback Yield % mean?
A high Buyback Yield % can signal that a stock is expensive relative to its fundamentals. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Plus Therapeutics and its competitors. Plus Therapeutics's current Buyback Yield % is -129.44. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Plus Therapeutics stock overvalued right now?
Plus Therapeutics (PSTV) has a current Buyback Yield % of -129.44. The current Buyback Yield % is -129.44. Plus Therapeutics' overall GF Score™ is 26/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Buyback Yield % calculated?
Buyback Yield % is calculated from a company's financial statements. For Plus Therapeutics (PSTV), the current Buyback Yield % is -129.44 as of Jul. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Plus Therapeutics Business Description

Other Exchanges XMP1:Germany
Address 6420 Levit Green Boulevard, Suite 210, Houston, TX, USA, 77021
Plus Therapeutics Inc is a clinical-stage pharmaceutical company that focuses on discovering, developing, commercializing and delivering complex treatments for patients with cancer and rare diseases. The company is working on a range of potential products, with its main programs targeting recurrent glioblastoma (GBM) and leptomeningeal metastases (LM). One of its key candidates, rhenium (186Re) obisbemeda, is specifically designed to treat central nervous system (CNS) cancers such as GBM, LM, and pediatric brain cancers (PBC).
26GF Score

Get the complete analysis for PSTV

Buyback Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$4.35
Price